Tuberculosis (TB)

Provider Related Resources

• Tuberculosis Treatment Recommendations
  CDC MMWR - revised treatment statement for suspect and confirmed TB disease (Exit DHS)

  • Frequently Asked Questions (Exit DHS)

   

• Tuberculosis Treatment Recommendations
  (with table of contents - bookmarks added to allow easy document navigation) (Exit DHS)

• Treatment of Latent Tuberculosis Infection
  1 page memo listing key points and resources  
  (PDF, 110 KB) 

• TB-Related WI Statutes and Administrative Code

• TB Patient Incentive Program  
  American Lung Association of WI (Exit DHS)
  

• TB Blood Test

• Tuberculin Skin Test Caliper Rulers
  
  

• National Tuberculosis Curriculum Consortium
  Tuberculosis Glossary (PDF, 16 MB)
  
  

• Links to material available in languages other than English

• Cultural Competency Links

• Revised latent TB treatment recommendations
  (PDF, 7 KB)

• Strategic Plan for the Elimination of TB in WI

• Forms

• Upcoming seminars and training opportunities

• Treatment Reminder Cards  
  Pocket Reference Cards

• Resources for Patient Care/Management 
  TB Education Center, Texas Department of Health
  (Exit DHS)

• Other Wisconsin TB Resources
  Includes: Anti-TB Therapy Program, TB Fact Sheets, TB-related statutes and administrative code, TB-related Medicaid information
  
  

• TB/Infection Control

Recent CDC publications: (Exit DHS)

• Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health-Care Settings MMWR 2005; 54 (No. RR-17, 1-141)
   (Exit DHS)

• Guidelines for the Investigation of Contacts of Persons with Infectious Tuberculosis: Recommendations - National Tuberculosis Controllers Association and CDC 
  MMWR 2005; 54 (No. RR-15, 1-37)  (Exit DHS)

• Guidelines for Using the QuantiFERON-TB Gold Test for Detecting Mycobacterium tuberculosis Infection, United States  
  MMWR 2005; 54 (No. RR-15, 49-55)  (Exit DHS)

• Controlling Tuberculosis in the United States  Recommendations from the American Thoracic society, CDC, and Infectious Diseases of America 
  MMWR 2005; 54 (No. RR-12)  (Exit DHS)

• Treatment of Tuberculosis
  American Thoracic Society, CDC, and Infectious Diseases Society of America 
  Am J Respir Crit Care Med 2003;167:603-662
   (Exit DHS)

• Interactive Core Curriculum on Tuberculosis:  What the Clinician Should Know 2004  (Exit DHS)

• Diagnostic standards and classification of tuberculosis in adults and children
  American Thoracic Society and CDC
  Am J Respir Crit Care Med 2000; 161:1376-1395
   (Exit DHS)

• Targeted tuberculin testing and treatment of latent tuberculosis infection
  MMWR 2000;49 RR-6  (Exit DHS)

• Improving Patient Adherence to Tuberculosis Treatment 1994  (Exit DHS)

• Tuberculosis Elimination Revisited: Obstacles, Opportunities, and a Renewed Commitment (ACET)
  Volume 48, RR-9, August 13, 1999  (Exit DHS)

• Updated Guidelines for the Use of Rifabutin or Rifampin for the Treatment and Prevention of Tuberculosis Among HIV-Infected Patients Taking Protease Inhibitors or Nonnucleoside Reverse Transcriptase Inhibitors
  MMWR 2004; 52(02);37  (Exit DHS)

• Prevention and Treatment of Tuberculosis among Patients Infected with Human Immunodeficiency Virus: Principles of Therapy and Revised Recommendations
  Volume 47, RR-20, October 30, 1998  (Exit DHS)

• Recommendations for Prevention and Control of Tuberculosis among Foreign-Born Persons
  Volume 47, RR-16, September 18, 1998  (Exit DHS)
  

PDF: The free Adobe Reader^® software is needed to view and print portable document format (PDF) files.  Learn more.

Last Revised: January 17, 2012